The relationship between vitamin C and TET activity has recently attracted attention in the context of leukaemia research, where vitamin C supplementation is being investigated as a form of epigenetic therapy to enhance TET2 activity in models of leukaemia characterised by decreased TET2 activity [95,121,122,124]. Here, TET2 is linked to leukemia.